REQUEST A DEMO
Total
USD $0.00
Search more companies

Marvel Drugs Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Marvel Drugs Pvt Ltd Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Marvel Drugs Pvt Ltd is an unlisted company, incorporated on 19/05/1986. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH1986PTC039868 and registration number is 039868. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
20, Nagin Mahal, 5Th Floor, 82, Veer Nariman Road, Churchgate
Mumbai; Maharashtra; Postal Code: 400020

Contact Details: Purchase the Marvel Drugs Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Marvel Drugs Pvt Ltd report to view the information.
Registered Capital:
Purchase the Marvel Drugs Pvt Ltd report to view the information.
Incorporation Date:
May 19, 1986
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
86.4%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Marvel Drugs Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.33%
Total operating revenue
4.28%
Operating profit (EBIT)
27.86%
EBITDA
25.57%
Net Profit (Loss) for the Period
35.14%
Total assets
21.53%
Total equity
17.79%
Operating Profit Margin (ROS)
8.32%
Net Profit Margin
7.41%
Return on Equity (ROE)
1.94%
Debt to Equity Ratio
7.01%
Quick Ratio
-0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?